Medically reviewed by Matthew Wosnitzer, MD Complement 3 glomerulopathy (C3G) is a rare kidney disease that is also ...

Ocugen has reported preliminary phase 2 data on its eye disease gene therapy, providing more evidence that the candidate may ...

European Commission approves Sobi’s Aspaveli for the treatment of C3G and primary IC-MPGN: Stockholm Monday, January 19, 2026, 10:00 Hrs [IST] Sobi, a global biopharma company u ...

Sobi® (STO: SOBI), today announced that the European Commission (EC) has approved Aspaveli® (pegcetacoplan) for the treatment of adult ...

Approximately 8,000 people in Europe are living with C3G or primary IC-MPGN Aspaveli (pegcetacoplan) is the first treatment of primary IC-MPGN and the first treatment for C3G and primary IC-MPGN ...

Could the power of positive thinking be enough to boost your immune system? According to a recent study, the answer may be ...

Moving Walls Group has acquired Adarth, an OOH SaaS company. This move boosts Moving Walls' presence in India's fast-growing ...

Ed Oliver's activation from Injured Reserve is likely to provide a massive boost for the Buffalo Bills’ defensive line, which has sorely missed his presence up ...

SANTA MONICA, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the “Company”), a leader in playable media trusted by global brands to reach and activate gaming audiences through ...

Ocugen also reported updated results from a phase 1 trial, which showed that ellipsoid zone (EZ) loss – which results in the ...

The gallery-style pop-up brings tastings, interactive calligraphy and premium gifting together to mark Maison Martell’s biggest Changi Airport animation in over a decade.

In this guide to the canine adolescent years, Christopher Pachel, DVM, DACVB, CABC (IAABC), breaks down this critical phase—from hormones to the prefrontal cortex—based on his 2026 VMX session in ...